Published in Pain on June 22, 2010
Morphine hyperalgesia gated through microglia-mediated disruption of neuronal Cl⁻ homeostasis. Nat Neurosci (2013) 2.37
Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia. Pharmacol Rev (2011) 1.66
Loss of μ opioid receptor signaling in nociceptors, but not microglia, abrogates morphine tolerance without disrupting analgesia. Nat Med (2017) 1.45
Toll-like receptors in chronic pain. Exp Neurol (2011) 1.29
Microglia: a promising target for treating neuropathic and postoperative pain, and morphine tolerance. J Formos Med Assoc (2011) 1.24
Pain and Poppies: The Good, the Bad, and the Ugly of Opioid Analgesics. J Neurosci (2015) 1.03
Morphine tolerance attenuates the resolution of postoperative pain and enhances spinal microglial p38 and extracellular receptor kinase phosphorylation. Neuroscience (2010) 0.96
Toll-like receptor 4 mutant and null mice retain morphine-induced tolerance, hyperalgesia, and physical dependence. PLoS One (2014) 0.92
Microglial activation involved in morphine tolerance is not mediated by toll-like receptor 4. J Anesth (2012) 0.89
Glial modulators as potential treatments of psychostimulant abuse. Adv Pharmacol (2014) 0.86
Glial responses after chorda tympani nerve injury. J Comp Neurol (2012) 0.83
Absence of μ opioid receptor mRNA expression in astrocytes and microglia of rat spinal cord. Neuroreport (2012) 0.82
Delta-opioid receptor analgesia is independent of microglial activation in a rat model of neuropathic pain. PLoS One (2014) 0.81
Targeting microglial purinergic signaling to improve morphine analgesia. Pain (2010) 0.81
Opioid-induced central immune signaling: implications for opioid analgesia. Headache (2015) 0.79
Ligand-gated purinergic receptors regulate HIV-1 Tat and morphine related neurotoxicity in primary mouse striatal neuron-glia co-cultures. J Neuroimmune Pharmacol (2013) 0.79
Procyanidins alleviates morphine tolerance by inhibiting activation of NLRP3 inflammasome in microglia. J Neuroinflammation (2016) 0.78
Antinociceptive Interactions between the Imidazoline I2 Receptor Agonist 2-BFI and Opioids in Rats: Role of Efficacy at the μ-Opioid Receptor. J Pharmacol Exp Ther (2016) 0.77
NADPH-oxidase 2 activation promotes opioid-induced antinociceptive tolerance in mice. Neuroscience (2013) 0.77
Allostatic Mechanisms of Opioid Tolerance Beyond Desensitization and Downregulation. Trends Pharmacol Sci (2016) 0.76
BK channels in microglia are required for morphine-induced hyperalgesia. Nat Commun (2016) 0.76
Regulation of morphine-induced synaptic alterations: Role of oxidative stress, ER stress, and autophagy. J Cell Biol (2016) 0.75
Complement factor C5a and C5a receptor contribute to morphine tolerance and withdrawal-induced hyperalgesia in rats. Exp Ther Med (2012) 0.75
Yokukansan, a Kampo medicine, prevents the development of morphine tolerance through the inhibition of spinal glial cell activation in rats. Integr Med Res (2015) 0.75
P2X4 Receptor Function in the Nervous System and Current Breakthroughs in Pharmacology. Front Pharmacol (2017) 0.75
Purinergic signaling in microglia in the pathogenesis of neuropathic pain. Proc Jpn Acad Ser B Phys Biol Sci (2017) 0.75
A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain (1988) 18.17
Ethical guidelines for investigations of experimental pain in conscious animals. Pain (1983) 17.70
Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci (2007) 11.11
P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature (2003) 6.04
Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science (1988) 5.56
Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu Rev Neurosci (1984) 4.87
Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy. J Pharmacol Exp Ther (2003) 3.69
Cellular and synaptic adaptations mediating opioid dependence. Physiol Rev (2001) 3.45
Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation. Pain (2005) 3.34
Perivascular macrophages are the primary cell type productively infected by simian immunodeficiency virus in the brains of macaques: implications for the neuropathogenesis of AIDS. J Exp Med (2001) 2.90
JNK-induced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain. J Neurosci (2009) 2.64
Extracellular ATP or ADP induce chemotaxis of cultured microglia through Gi/o-coupled P2Y receptors. J Neurosci (2001) 2.54
Regulated ATP release from astrocytes through lysosome exocytosis. Nat Cell Biol (2007) 2.38
Dissociation of microglial activation and neuropathic pain behaviors following peripheral nerve injury in the rat. J Neuroimmunol (1997) 2.15
The role of spinal neuroimmune activation in morphine tolerance/hyperalgesia in neuropathic and sham-operated rats. J Neurosci (2002) 2.02
Up-regulation of P2X4 receptors in spinal microglia after peripheral nerve injury mediates BDNF release and neuropathic pain. J Neurosci (2008) 1.97
The function of microglia through purinergic receptors: neuropathic pain and cytokine release. Pharmacol Ther (2005) 1.90
A monoclonal antibody to a novel differentiation antigen on human macrophages associated with the down-regulatory phase of the inflammatory process. Exp Cell Biol (1987) 1.86
Neuronal somatic ATP release triggers neuron-satellite glial cell communication in dorsal root ganglia. Proc Natl Acad Sci U S A (2007) 1.85
Inhibition of neuropathic pain by selective ablation of brainstem medullary cells expressing the mu-opioid receptor. J Neurosci (2001) 1.72
Cellular mechanisms of neuropathic pain, morphine tolerance, and their interactions. Proc Natl Acad Sci U S A (1999) 1.69
Vesicular release of ATP at central synapses. Pflugers Arch (2006) 1.69
Attenuation of morphine tolerance, withdrawal-induced hyperalgesia, and associated spinal inflammatory immune responses by propentofylline in rats. Neuropsychopharmacology (2004) 1.61
The role of macrophages, perivascular cells, and microglial cells in the pathogenesis of experimental autoimmune encephalomyelitis. Glia (1995) 1.55
Neuroimmune interactions and pain: focus on glial-modulating targets. Curr Opin Investig Drugs (2008) 1.50
Involvement of P2X4 and P2Y12 receptors in ATP-induced microglial chemotaxis. Glia (2007) 1.47
Adenosine release may mediate spinal analgesia by morphine. Trends Pharmacol Sci (1989) 1.45
Spinal microglial and perivascular cell cannabinoid receptor type 2 activation reduces behavioral hypersensitivity without tolerance after peripheral nerve injury. Anesthesiology (2008) 1.39
Morphine enhances microglial migration through modulation of P2X4 receptor signaling. J Neurosci (2009) 1.38
Identity of ED2-positive perivascular cells in rat brain. J Neurosci Res (1989) 1.38
Efficacy of propentofylline, a glial modulating agent, on existing mechanical allodynia following peripheral nerve injury. Brain Behav Immun (2006) 1.35
Spinal cannabinoid receptor type 2 activation reduces hypersensitivity and spinal cord glial activation after paw incision. Anesthesiology (2007) 1.30
Modulation of microglia can attenuate neuropathic pain symptoms and enhance morphine effectiveness. Pharmacol Rep (2008) 1.29
A novel role of minocycline: attenuating morphine antinociceptive tolerance by inhibition of p38 MAPK in the activated spinal microglia. Brain Behav Immun (2007) 1.28
Behavioral phenotypes of mice lacking purinergic P2X4 receptors in acute and chronic pain assays. Mol Pain (2009) 1.27
A comparison of spinal Iba1 and GFAP expression in rodent models of acute and chronic pain. Brain Res (2008) 1.26
Differential spinal cord gene expression in rodent models of radicular and neuropathic pain. Anesthesiology (2006) 1.18
Intrathecal catheterization alone induces neuroimmune activation in the rat. Eur J Pain (1997) 1.18
Morphine-induced changes of gene expression in the brain. Addict Biol (2005) 1.18
Mu opioid receptor regulation and opiate responsiveness. AAPS J (2005) 1.16
Shedding of CD163, a novel regulatory mechanism for a member of the scavenger receptor cysteine-rich family. Biochem Biophys Res Commun (1999) 1.15
Cell-type specific activation of p38 and ERK mediates calcitonin gene-related peptide involvement in tolerance to morphine-induced analgesia. FASEB J (2009) 1.11
Blocking mu opioid receptors in the spinal cord prevents the analgesic action by subsequent systemic opioids. Brain Res (2006) 1.10
Focal peripheral nerve injury induces leukocyte trafficking into the central nervous system: potential relationship to neuropathic pain. Pain (2002) 1.09
Cell-specific actions of HIV-Tat and morphine on opioid receptor expression in glia. J Neurosci Res (2008) 1.09
Akt activation is involved in P2Y12 receptor-mediated chemotaxis of microglia. J Neurosci Res (2008) 1.02
Mechanical allodynia and spinal up-regulation of P2X4 receptor in experimental autoimmune neuritis rats. Neuroscience (2008) 1.02
Transcriptional and translational regulation of glial activation by morphine in a rodent model of neuropathic pain. J Pharmacol Exp Ther (2005) 1.01
ATP release from dorsal spinal cord synaptosomes: characterization and neuronal origin. Brain Res (1993) 0.94
ATP induces long-term potentiation of C-fiber-evoked field potentials in spinal dorsal horn: the roles of P2X4 receptors and p38 MAPK in microglia. Glia (2009) 0.92
Morphine, capsaicin and K+ release purines from capsaicin-sensitive primary afferent nerve terminals in the spinal cord. J Pharmacol Exp Ther (1989) 0.90
Glial and neuronal opioid receptors: apparent positive cooperativity observed in intact cultured cells. Brain Res (1988) 0.89
Identification of an opioid peptide secreted by rat embryonic mixed brain cells as a promoter of macrophage migration. Eur J Neurosci (2000) 0.85
Systemic morphine inhibits dorsal horn projection neurons through spinal cholinergic system independent of descending pathways. J Pharmacol Exp Ther (2005) 0.85
Roles of calcitonin gene-related peptide and its receptors in pain-related behavioral responses in the central nervous system. Neurosci Biobehav Rev (2009) 0.84
Current review of in vivo GBM rodent models: emphasis on the CNS-1 tumour model. ASN Neuro (2011) 1.44
Propentofylline decreases tumor growth in a rodent model of glioblastoma multiforme by a direct mechanism on microglia. Neuro Oncol (2011) 0.93
Evidence for a role of endocannabinoids, astrocytes and p38 phosphorylation in the resolution of postoperative pain. PLoS One (2010) 0.91
Critical role of microglial CD40 in the maintenance of mechanical hypersensitivity in a murine model of neuropathic pain. Eur J Immunol (2009) 0.90
Propentofylline targets TROY, a novel microglial signaling pathway. PLoS One (2012) 0.89
Antinociception and the new COX inhibitors: research approaches and clinical perspectives. CNS Drug Rev (2003) 0.85
Spinal cannabinoid receptor type 2 agonist reduces mechanical allodynia and induces mitogen-activated protein kinase phosphatases in a rat model of neuropathic pain. J Pain (2012) 0.85
Spinal mitogen-activated protein kinase phosphatase-3 (MKP-3) is necessary for the normal resolution of mechanical allodynia in a mouse model of acute postoperative pain. J Neurosci (2013) 0.80
Increased glutamate uptake in astrocytes via propentofylline results in increased tumor cell apoptosis using the CNS-1 glioma model. J Neurooncol (2013) 0.75
Depression and pain: does ketamine improve the quality of life of patients in chronic pain by targeting their mood? Anesthesiology (2011) 0.75